AramarkARMK
Price$53.55Intrinsic value$48.0810% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $19.8B+14.0% YoYTTM through 3 Jul 2026
Net Income $382.9M+45.9% YoYTTM through 3 Jul 2026
Free Cash Flow $443MTTM through 3 Jul 2026

Margins

Current
EBITDA Margin7.0%
Operating Margin44.7%
Net Margin1.9%

Returns

11.1%ROE
2.7%ROA
4.3%ROIC

Balance Sheet Health

Debt / Equity1.84x
Current Ratio1.28x
Net Debt$5.6B
Cash & Equivalents$499.4M

Quality Metrics

Altman Z-Score2.61
Piotroski F-Score6 / 9
FCF Margin2.2%
Rule of 403.5
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $18.5B
Diluted EPS$1.43TTM
'19'20'21'22'23'24'25
FY2025: $1.22

Dividend

$0.24Per share, FY20260.42%Yield-5.5%5-yr growth

Capital Allocation

Capex Intensity2.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.